Severe urticaria due to recombinant interferon beta-1a [2]

British Journal of Dermatology

Volumn 148, Issue 1, 2003, Pages 172-

  Mazzeo, L ^a   Ricciardi, L ^a   Fazio, M C ^b   Fogliani, O ^a   Fedele, R ^a   Ferlazzo, E ^b   Isola, S ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; BETAMETHASONE; CETIRIZINE; CHLORPHENIRAMINE MALEATE; DEFLAZACORT; GLATIRAMER; METHYLPREDNISOLONE;

ADULT; ANAPHYLACTIC SHOCK; BLOOD DISEASE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ACTIVITY; DRUG WITHDRAWAL; FEMALE; FLU LIKE SYNDROME; HUMAN; INJECTION PAIN; INJECTION SITE; LABORATORY TEST; LETTER; MENSTRUATION DISORDER; MULTIPLE SCLEROSIS; PRICK TEST; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SKIN DEFECT; SKIN IRRITATION; SKIN MANIFESTATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; URTICARIA;

EID: 0037238416     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.50802.x     Document Type: Letter

References (5)

1. Yong VW, Chabot S, Stuve O, Williams G. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 1998; 51: 682-9.
2. Walther EU, Hohfeld R. Multiple sclerosis - side effects of interferon beta therapy and their management. Neurology 1999; 53: 1622-7.
3. Corona T, Leon C, Ostrosky-Zeicher L. Severe anaphylaxis with recombinant interferon beta. Neurology 1999; 52: 425.
4. Brown DL, Login IS, Borish L, Powers PL. An urticarial IgE mediated reaction to interferon beta-1b. Neurology 2001; 56: 1416-17.
5. Gonzalez FJ, Leyva L, Posadas S et al. Participation of T lymphocytes in cutaneous allergic reactions to drugs. Clin Exp Allergy 1998; 28 (Suppl. 4): 3-6.